Skip to content

MRC (UKRI)

ME/CFS Priority Area

Rolling priority notice; apply through the most relevant MRC grant or fellowship opportunity

Last verified:

Is this grant right for you? Check your personalised match score. 30s, no email. See my matches →

The MRC ME/CFS Priority Area is a standing priority notice encouraging applications addressing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) research needs identified by the 2022 James Lind Alliance Priority Setting Partnership. Researchers can apply through any active MRC grant or fellowship scheme; applications that score at the same median level receive preferential funding. Multidisciplinary and international teams are supported, and applicants should contact mecfs@mrc.ukri.org before submitting.

Details

Funder MRC (UKRI)
Consortium Optional — MRC encourages (but does not require) partnerships with other funders or industrial/charitable partners; multidisciplinary teams and international co-leads are supported
Frequency Continuous
Eligible countries GB

Eligibility & scope

Priority funding notice (active since 2003) encouraging high-quality applications to any MRC grant or fellowship scheme addressing ME/CFS research priorities identified by the 2022 James Lind Alliance Priority Setting Partnership. Applications attaining the same median ranking score receive prioritisation for funding. Applicants should contact mecfs@mrc.ukri.org before applying.

Who Should Apply

  • Researchers based at eligible UK institutions
  • Applicants aligning their work with the 2022 James Lind Alliance ME/CFS research priorities
  • Multidisciplinary teams and those planning international collaboration
  • Any career stage eligible through MRC grant and fellowship schemes

Key Dates

  • Rolling priority notice; apply through any active MRC grant or fellowship scheme
  • Contact mecfs@mrc.ukri.org before submitting your application

Tips for Applicants

  • Align your research explicitly with the 2022 James Lind Alliance ME/CFS priorities before drafting; the priority notice is selective on scope, not all ME/CFS research qualifies.
  • Contacting the ME/CFS team early increases the chance your proposed work fits the priority framing and merits prioritisation at score parity.
  • MRC encourages co-funding partnerships and international leads; highlighting cross-funder or cross-sector collaboration may strengthen implementation scores.

Frequently Asked Questions

What is the MRC ME/CFS Priority Area?

It is a standing funding priority encouraging applications to any active MRC grant or fellowship scheme that address ME/CFS research needs identified by the 2022 James Lind Alliance Priority Setting Partnership.

How do I apply for MRC ME/CFS Priority Area funding?

Apply through any active MRC grant or fellowship scheme; applications addressing the priority area receive preferential funding at score parity. Contact mecfs@mrc.ukri.org before submitting.

Who can apply for MRC ME/CFS Priority Area funding?

Researchers based at eligible UK institutions across any career stage and discipline, provided their proposal aligns with the 2022 James Lind Alliance ME/CFS research priorities.

Can international researchers apply for MRC ME/CFS funding?

International co-leads are supported, though the applicant must be based at a UK institution. MRC encourages multidisciplinary and international partnerships.

mecfsmyalgic-encephalomyelitismrcukpriority-arearolling-call

Related on Grantsby

Summary generated by AI based on published grant information. Always verify details on the funder's website.

More from MRC (UKRI)

Browse all open grants →

Browse Related

Could ME/CFS Priority Area be right for you?

See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →